Newsroom

Sorted by: Latest
-

Deep Shifts in Human Sentiment Are Redefining Economic, Health, and Workplace Norms, Oliver Wyman Forum Report Finds

NEW YORK--(BUSINESS WIRE)--Oliver Wyman Forum, the think tank of Oliver Wyman, a global management consulting firm and a business of Marsh (NYSE: MRSH), today released a comprehensive study of consumer and workplace sentiment with insights from their five-year, global 300,000 Voices project. The report, 300,000 Voices...And What They Tell Us About The Next Era Of Global Change, shows that geoeconomic and technological disruptions are increasing emotional strain and fundamentally reshaping how p...
-

TMA Systems Introduces MEX in North America, Expanding Its Portfolio for Asset-Intensive Operations

TULSA, Okla.--(BUSINESS WIRE)--TMA Systems launches MEX in North America, a technician-first CMMS for asset-intensive, field-based operations focused on uptime and reliability....
-

SAMSE : Bilan SEMESTRIEL S2 du contrat de liquidité contracté avec la Société de Bourse Gilbert Dupont

GRENOBLE, France--(BUSINESS WIRE)--Regulatory News: Au titre du contrat de liquidité confié par la société SAMSE (Paris:SAMS) à la Société de Bourse Gilbert Dupont, à la date du 31 décembre 2025, les moyens suivants figuraient au compte de liquidité : - Nombre d’actions : 2 556 - Solde en espèces: 76 610,45 € Au cours du 2ème semestre 2025, il a été négocié un total de : ACHAT 2 889 titres 387 840,50 € 461 transactions VENTE 2 203 titres 290 612,50 € 346 transactions Il est rappelé que lors du...
-

MaaT Pharma Announces First Patient Randomized in IMMUNOLIFE Phase 2 Study Sponsored by Gustave Roussy, To Explore the Role of the Gut Microbiome To Overcome ICI Resistance in Advanced NSCLC Patients with Antibiotic-Induced Dysbiosis

LYON, France--(BUSINESS WIRE)--MaaT Pharma Announces First Patient Randomized in IMMUNOLIFE Phase 2 Study Sponsored by Gustave Roussy, in Advanced NSCLC patients....
-

MaaT Pharma annonce la randomisation du premier patient dans IMMUNOLIFE, essai Phase 2 promu par Gustave Roussy évaluant le rôle du microbiote pour contourner la résistance aux ICI chez des patients CPNPC avancé avec dysbiose liée aux antibiotiques

LYON, France--(BUSINESS WIRE)--Regulatory News: MaaT Pharma (EURONEXT: MAAT – la “Société”), société de biotechnologies en stade clinique avancé, leader dans le développement de Microbiome Ecosystem TherapiesTM (MET) visant à améliorer la survie des patients atteints de cancers grâce à la modulation du système immunitaire, annonce que le premier patient a été randomisé dans l’essai clinique de Phase 2 IMMUNOLIFE. Cet essai randomisé multicentrique évalue le potentiel d’une microbiothérapie féca...
-

CRISP & GREEN® Proudly Partners With Olympic Gold Medalist Shawn Johnson East & Husband Andrew East

NASHVILLE, Tenn.--(BUSINESS WIRE)--CRISP & GREEN® is proudly announcing a partnership with Olympic Gold Medalist Shawn Johnson East and former NFL player Andrew East....
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Equity Income UCITS ETF 19.01.2026 FGBL.LN IE00BYTH6121 76,765.00 USD 6,875,246.23 89.562  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 19.01.2026 FKUD IE00BD9N0445 118,031.00 GBP 3,448,446.25 29.216  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 19.01.2026 FKU IE00B8X9NZ57 209,100.00 GBP 8,704,280.33 41.627  ...
-

Soil Environmental Remediation Market - Global Forecast 2026-2032 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Soil Environmental Remediation Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Soil Environmental Remediation Market is experiencing robust growth, expanding from USD 68.58 billion in 2025 to USD 73.44 billion in 2026, with projections indicating a CAGR of 7.68%, reaching USD 115.18 billion by 2032. This comprehensive report provides key insights into market dynamics, enabling strategic planning and decision-making for s...